Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

NCT02733380 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER_GOV

Sponsor class

Conditions

Diffuse Large B-cell Lymphoma

Interventions

DRUG: Chidamide
DRUG: Vinorelbine
DRUG: Liposomal Doxorubicin or mitoxantrone
DRUG: Dexamethasone
DRUG: Thalidomide

Sponsor

Henan Cancer Hospital